GoKawiilRubedo Life Sciences reports topical drug cut skin's biological age in small trial
Rubedo Life Sciences, a Mountain View biotech, presented early data at the Aging Research and Drug Discovery meeting showing its experimental topical cream reduced skin biological age by about two years on average in an 11-person trial. The cream targets senescent 'zombie' skin cells in patients with atopic dermatitis, and an independent analysis by Mitra Bio found reduced inflammation markers and a 10 percent rise in elasticity-related collagen after four weeks of use.